State of Alaska Department of Revenue’s iTeos Therapeutics ITOS Stock Holding History

State of Alaska Department of Revenue’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,485	Closed	-$180K	–	1608
2023 Q3	$180K	Buy	16,485 +248	+2%	+$3.17K	﹤0.01%	1586
2023 Q2	$214K	Sell	16,237 -572	-3%	-$8.16K	﹤0.01%	1594
2023 Q1	$228K	Sell	16,809 -283	-2%	-$5.07K	﹤0.01%	1582
2022 Q4	$333K	Buy	17,092 +97	+0.6%	+$1.9K	﹤0.01%	1514
2022 Q3	$323K	Buy	16,995 +1,675	+11%	+$38.6K	﹤0.01%	1493
2022 Q2	$315K	Buy	15,320 +1,330	+10%	+$31.6K	﹤0.01%	1518
2022 Q1	$450K	Buy	+13,990	New	+$508K	﹤0.01%	1431

Other funds holding ITOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State of Alaska Department of Revenue's ITOS Position: Q4 2023 in Review

State of Alaska Department of Revenue sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 16,485 shares — an estimated $180K sold.

State of Alaska Department of Revenue first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $450K in Q1 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

State of Alaska Department of Revenue reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
State of Alaska Department of Revenue sold 16,485 iTeos Therapeutics shares in Q4 2023, an estimated $180K.
State of Alaska Department of Revenue first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
State of Alaska Department of Revenue's iTeos Therapeutics position peaked at $450K in Q1 2022.
138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q4 2023, filed 19 Jan 2024.